Tempest Therapeutics Statistics
Total Valuation
TPST has a market cap or net worth of $23.87 million. The enterprise value is $19.49 million.
Important Dates
The last earnings date was Tuesday, November 12, 2024, after market close.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TPST has 26.57 million shares outstanding. The number of shares has increased by 61.11% in one year.
Current Share Class | 26.57M |
Shares Outstanding | 26.57M |
Shares Change (YoY) | +61.11% |
Shares Change (QoQ) | +14.46% |
Owned by Insiders (%) | 0.75% |
Owned by Institutions (%) | 13.16% |
Float | 22.86M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.08 |
P/TBV Ratio | 2.08 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 1.55.
Current Ratio | 1.69 |
Quick Ratio | 1.58 |
Debt / Equity | 1.55 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -24.63 |
Financial Efficiency
Return on equity (ROE) is -691.89% and return on invested capital (ROIC) is -90.85%.
Return on Equity (ROE) | -691.89% |
Return on Assets (ROA) | -77.01% |
Return on Capital (ROIC) | -90.85% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.09M |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.03% in the last 52 weeks. The beta is -2.78, so TPST's price volatility has been lower than the market average.
Beta (5Y) | -2.78 |
52-Week Price Change | -74.03% |
50-Day Moving Average | 1.16 |
200-Day Moving Average | 2.43 |
Relative Strength Index (RSI) | 37.84 |
Average Volume (20 Days) | 3,060,399 |
Short Selling Information
The latest short interest is 2.64 million, so 9.93% of the outstanding shares have been sold short.
Short Interest | 2.64M |
Short Previous Month | 3.72M |
Short % of Shares Out | 9.93% |
Short % of Float | 11.54% |
Short Ratio (days to cover) | 0.39 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.62M |
Pretax Income | -31.75M |
Net Income | -35.52M |
EBITDA | -35.20M |
EBIT | -35.62M |
Earnings Per Share (EPS) | -$1.58 |
Full Income Statement Balance Sheet
The company has $22.12 million in cash and $17.74 million in debt, giving a net cash position of $4.38 million or $0.16 per share.
Cash & Cash Equivalents | 22.12M |
Total Debt | 17.74M |
Net Cash | 4.38M |
Net Cash Per Share | $0.16 |
Equity (Book Value) | 11.46M |
Book Value Per Share | 0.43 |
Working Capital | 9.58M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$29.05 million and capital expenditures -$439,000, giving a free cash flow of -$29.49 million.
Operating Cash Flow | -29.05M |
Capital Expenditures | -439,000 |
Free Cash Flow | -29.49M |
FCF Per Share | -$1.11 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |